| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 22 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 11.08.2009 | | |
| | Composition | | haemophilus influenzae inactivatum A/Brisbane/59/2007 (H1N1)-like strain (A/Brisbane/59/2007 IVR-148) 15 µg, haemophilus influenzae inactivatum A/Brisbane/10/2007 (H3N2)-like strain (A/Uruguay/716/2007 NYMC X-175C) 15 µg, haemophilus influenzae inactivatum B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
